Spanish Association of Pediatrics Vaccines Advisory Committee, Spain.
An Pediatr (Barc). 2012 Jan;76(1):43.e1-23. doi: 10.1016/j.anpedi.2011.10.008. Epub 2011 Dec 16.
The Advisory Committee on Vaccines of the Spanish Association of Pediatrics (CAV-AEP) updates the immunization schedule every year, taking into account epidemiological data as well as evidence on the effectiveness and efficiency of vaccines. The present schedule includes grades of recommendation. We have graded as routine vaccinations those that the CAV-AEP believes all children should receive; as recommended those that fit the profile for universal childhood immunization and would ideally be given to all children, but that can be prioritized according to the resources available for their public funding; and as risk group vaccinations those that specifically target individuals in situations of risk. Immunization schedules tend to be dynamic and adaptable to ongoing epidemiological changes. Nevertheless, the achievement of a unified immunization schedule in all regions of Spain is a top priority for the CAV-AEP. Based on the latest epidemiological trends, the main changes introduced to the schedule are the administration of the first dose of the MMR and the varicella vaccines at age 12 months (12-15 months) and the second dose at age 2-3 years, as well as the administration of the Tdap vaccine at age 4-6 years, always followed by another dose at 11-14 years of age. The CAV-AEP believes that the coverage of vaccination against human papillomavirus in girls aged 11-14 years must increase. It reasserts its recommendation to include vaccination against pneumococcal disease in the routine immunization schedule. Universal vaccination against varicella in the second year of life is an effective strategy and therefore a desirable objective. Vaccination against rotavirus is recommended in all infants due to the morbidity and elevated healthcare burden of the virus. The Committee stresses the need to vaccinate population groups considered at risk against influenza and hepatitis A. Finally, it emphasizes the need to bring incomplete vaccinations up to date following the catch-up immunization schedule.
西班牙儿科学会疫苗咨询委员会 (CAV-AEP) 每年都会根据流行病学数据以及疫苗的有效性和效率证据更新免疫计划。本计划包括推荐等级。我们将 CAV-AEP 认为所有儿童都应接种的疫苗归类为常规疫苗;将适合普遍儿童免疫计划并理想上应给予所有儿童的疫苗归类为推荐疫苗,但可以根据其公共资金的可用资源进行优先排序;将专门针对处于风险状况的个体的疫苗归类为风险群体疫苗。免疫计划往往是动态的,并能适应不断变化的流行病学情况。然而,实现西班牙所有地区统一的免疫计划是 CAV-AEP 的首要任务。根据最新的流行病学趋势,计划中主要的变化是在 12 个月(12-15 个月)时接种第一剂麻疹、腮腺炎、风疹疫苗和水痘疫苗,在 2-3 岁时接种第二剂,以及在 4-6 岁时接种 Tdap 疫苗,之后在 11-14 岁时再接种一剂。CAV-AEP 认为必须增加对 11-14 岁女孩接种人乳头瘤病毒疫苗的覆盖率。它重申了其建议,即在常规免疫计划中纳入针对肺炎球菌疾病的疫苗接种。在第二年对所有婴儿进行水痘的普遍疫苗接种是一种有效的策略,因此是一个理想的目标。由于轮状病毒引起的发病率和高昂的医疗保健负担,建议所有婴儿接种轮状病毒疫苗。委员会强调需要为被认为处于流感和甲型肝炎风险中的人群接种疫苗。最后,它强调需要根据补种免疫计划更新未完成的疫苗接种。